Home › Funds › ALLEN OPERATIONS LLC › DNA
ALLEN OPERATIONS LLC position in DNA
GINKGO BIOWORKS HOLDINGS INC · Health Care
ALLEN OPERATIONS LLC reported holding 61,951 shares of DNA (GINKGO BIOWORKS HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$795K, representing 0.08% of its reported portfolio and ranking #31 among its reported holdings. ALLEN OPERATIONS LLC has disclosed DNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How ALLEN OPERATIONS LLC's DNA position evolved
ALLEN OPERATIONS LLC first disclosed a stake in DNA in Q3 2023 at 2,478,098 shares (US$4.5M). Across 13 filings, ALLEN OPERATIONS LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 61,951 shares valued at US$795K. Notable position changes include a 97% trim in Q3 2024 (shares rose 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.48M | $4.49M | New |
| Q4 2023 | 2.48M | $4.19M | Hold |
| Q1 2024 | 2.48M | $2.87M | Hold |
| Q2 2024 | 2.48M | $827.68K | Hold |
| Q3 2024 | 61.95K | $504.90K | Reduce |
| Q4 2024 | 61.95K | $608.36K | Hold |
| Q1 2025 | 61.95K | $353.12K | Hold |
| Q2 2025 | 61.95K | $696.95K | Hold |
| Q3 2025 | 61.95K | $903.25K | Hold |
| Q4 2025 | 61.95K | $514.81K | Hold |
| Q1 2026 | 61.95K | $379.76K | Hold |
| Q2 2026 | 61.95K | $613.93K | Hold |
| Q3 2026 | 61.95K | $794.83K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DNA and 13F data
DNA (GINKGO BIOWORKS HOLDINGS INC) is a Health Care company. 34 other funds we track also report a position in DNA — the largest reported positions include Anchorage Capital Group, L.L.C. (US$17.3M), FORBES J M & CO LLP (US$12.5M), SB INVESTMENT ADVISERS (UK) LTD (US$6.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DNA
- Anchorage Capital Group, L.L.C. 1.75M sh · $17.31M · Q2 2026
- FORBES J M & CO LLP 977.37K sh · $12.54M · Q3 2026
- SB INVESTMENT ADVISERS (UK) LTD 610.73K sh · $6.05M · Q2 2026
More on ALLEN OPERATIONS LLC
FAQ
How long has ALLEN OPERATIONS LLC held DNA?
ALLEN OPERATIONS LLC has disclosed DNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is ALLEN OPERATIONS LLC's current position in DNA?
As of Q3 2026, ALLEN OPERATIONS LLC holds 61.95K shares of DNA (GINKGO BIOWORKS HOLDINGS INC), valued at $794.83K, representing 0.08% of its reported portfolio and ranking #31.
Has ALLEN OPERATIONS LLC been buying or selling DNA?
In the latest 13F filing (Q3 2026), ALLEN OPERATIONS LLC held unchanged its position in DNA.
Which other funds hold DNA?
Other major institutional holders of DNA include Anchorage Capital Group, L.L.C., FORBES J M & CO LLP, SB INVESTMENT ADVISERS (UK) LTD, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.